The Natural History of Metachromatic Leukodystrophy Study (HOME Study)

Status Active, not recruiting

Clinical Trial Summary

The primary aims of the HOME Study are to: - Design and implement a natural history study for metachromatic leukodystrophy to serve as a source of external control data, to augment or replace concurrent controls in clinical trials; - Pilot test and develop guidance on how to design, conduct, and analyze the data from a natural history study to support adaptive trial designs for regulatory use; - Reduce burden of participation in trials and provide a potential solution to patient recruitment challenges, particularly for RCT's; and - Design approaches that support remote participation in studies.

Clinical Trial Description

The HOME Study is a web-based natural history study for patients with metachromatic leukodystrophy. It is hosted by the National Organization for Rare Disorders (NORD); an independent non-profit patient advocacy organization dedicated to individuals with rare diseases and the organizations who serve them. The study collects information from participants (or their authorized respondents, heretofore referred to collectively as "participants") who are affected by metachromatic leukodystrophy. Data are collected at pre-baseline, baseline, 3, 6, 9, and 12 months through online surveys, telephone Interviews, web-based virtual assessments with a clinical study coordinator, and a (optional - only for U.S. residents) mobile application. Data entered into this study includes name, date of birth, diagnosis, treatments, medical history, family history, quality of life, disease progression, treatment - past and proposed, general medical information, genetic test results and mutations, blood level results, upload of medical records. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04628364
Study type	Observational
Source	National Organization for Rare Disorders
Contact
Status	Active, not recruiting
Phase
Start date	October 1, 2020
Completion date	June 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00383448` - HSCT for High Risk Inherited Inborn Errors	Phase 2
Recruiting	`NCT05687474` - Baby Detect : Genomic Newborn Screening
Completed	`NCT01303146` - Efficacy METAZYM for the Treatment Metachromatic Leukodystrophy Treated With Hematopoietic Stem Cell Transplantation	Phase 2
Enrolling by invitation	`NCT03655223` - Early Check: Expanded Screening in Newborns
Enrolling by invitation	`NCT05368038` - ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
Active, not recruiting	`NCT01801709` - Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy	Phase 1/Phase 2
Completed	`NCT00683189` - Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy	N/A
Recruiting	`NCT02171104` - MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis	Phase 2
Active, not recruiting	`NCT02699190` - LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Active, not recruiting	`NCT03392987` - A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)	Phase 2
Recruiting	`NCT02559830` - Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy	Phase 1/Phase 2
Active, not recruiting	`NCT00639132` - The Natural History of Metachromatic Leukodystrophy
Completed	`NCT00004378` - Stem Cell Transplantation (SCT) for Genetic Diseases	N/A
Completed	`NCT00176904` - Stem Cell Transplant for Inborn Errors of Metabolism	Phase 2/Phase 3
Active, not recruiting	`NCT04283227` - OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)	Phase 3
Recruiting	`NCT03047369` - The Myelin Disorders Biorepository Project
Recruiting	`NCT04925349` - Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
Active, not recruiting	`NCT00005900` - Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation	N/A
Active, not recruiting	`NCT01560182` - Gene Therapy for Metachromatic Leukodystrophy (MLD)	Phase 1/Phase 2
Completed	`NCT01586455` - Human Placental-Derived Stem Cell Transplantation	Phase 1